Waltz Health and Fresenius Kabi are moving to offer three biosimilars through a direct-to-payer model, bypassing traditional wholesaler and pharmacy benefit manager rebate channels entirely. The partnership represents a significant shift in
Dividend investors are increasingly turning their attention to high-yield stocks that appear undervalued when measured against forward earnings expectations for 2027. In an environment where interest rates remain a key concern for
More
Gilead Sciences has secured regulatory approval from the US Food and Drug Administration for Bixlenvo, a new once-daily single-tablet HIV treatment combining two established compounds. The pill pairs bictegravir, the active backbone
More
The US Department of Justice has reached a $400 million settlement with TikTok, ByteDance, and affiliated entities over violations of children’s online privacy laws. The settlement resolves litigation concerning compliance with the
More
London’s blue-chip index closed sharply lower on Thursday as investor anxiety over inflation and interest rates overshadowed a powerful rally in technology stocks driven by Nvidia. The FTSE 100 ended the session
More
Cleveland Federal Reserve President Beth Hammack has renewed her call for higher interest rates, warning the central bank remains too far from its inflation target. Speaking at the Fed’s annual symposium in
More
Revolution Medicines (RVMD) is pushing forward with the commercial launch of daraxonrasib, branded as Rasonque, following a landmark approval from the US Food and Drug Administration. The drug represents a historic milestone
More
The HHS Office of Inspector General has issued Advisory Opinion 26-17, offering a favorable ruling on a proposed independent charity patient assistance program. The program was put forward by a nonprofit, tax-exempt
More
The FTSE 100 fell 105 points to close at 10,772.98 on Thursday, leaving London sharply out of step with a Wall Street session that opened firmly higher. The primary cause of the
More
Dollar General posted second-quarter 2026 sales that exceeded analyst estimates, sending shares climbing sharply higher in a strong session for the discount retailer. The stock jumped 12.4% following the results, reflecting investor
More
The Trump administration is preparing to announce fresh drug-pricing agreements with several midsized biotech companies as part of its most favoured nation pricing push. The companies involved will agree to provide discounts
More